Guideline / position statementindependent cross-checkabstract only checked I-RES-02 standard review

EU hormone ban in livestock

Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists

Overview

Council of the EU. Official Journal of the EC 1996

The EU prohibits hormonal growth promoters in farm animals.

Does the study support the specific claim? Unclear · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Ban hormones.

How was the study done?

Directive.

What was actually found?

Prohibition.

What do the results mean in everyday life?

No legal hormone fattening in EU.

What are the study's limitations?

Title only read.

What does it say about Elawady's specific claim?

Contradicts claim for EU.

Do the results apply to Germany and Europe?

High.

Scientific in-depth review

1. Full reference

Authors
Council of the EU
Journal
Official Journal of the EC
Year
1996
Identifier
Verification
verified – Text read on legislation.gov.uk (copy of EU legislation as adopted, published up to 31 Dec 2020); EUR-Lex returned HTTP 202 (bot check) and could not be read. Fetched 2026-10-25.
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not applicable (official document)

2. Research question

3. Study design and population

Study design
Guideline / position statement – EU directive prohibiting hormonal/thyrostatic substances and beta-agonists in stockfarming
Country

EU

Period

1996

4. Methods and endpoints

5. Actual results

Results

Title read: 'Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of ß-agonists'. Article texts could not be extracted.

Absolute risks

not reported

6. Strengths

  • Binding law

7. Weaknesses

  • Only title/contents page read

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
not assessable

9. Assessment of the statistical interpretation

10. Relevance to the specific claim

C-RES-04, C-FSH-16.

11. Independent contrary findings

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Hormone ban reference.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biasnot assessable
Precision of resultsnot applicable
Directnessdirect
Reproducibilitynot replicated
Consistency with the overall evidenceunknown
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Article-level exceptions (therapeutic use) not read.

15. Linked fact checks